CCO Expert Recap

Part 2: Pharmacology, Metabolic Complications, Hepatitis Coinfection, and Opportunistic Diseases

Source: CCO Independent Conference Coverage of the 2004 International AIDS Conference*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Part 2: Pharmacology, Metabolic Complications, Hepatitis Coinfection, and Opportunistic Diseases

Program Director: John P. Phair, MD

Faculty:

Judith S. Currier, MD, MSc

CREDIT INFORMATION

Release Date: August 04, 2004

Expiration Date: August 03, 2005

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the latest findings of the pharmacologic issues in the management of HIV-infected patients
Review the management of metabolic and other complications occurring in patients receiving antiretroviral therapy
Describe new data on hepatitis coinfection and opportunistic diseases in HIV-infected patients

CCO Expert Recap combining slides with audio commentary by Judith S. Currier, MD, MSc. CME credits will be available.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.